Table 9.
SID amino acids (%) |
mTOR | S6K1 | eEF2 | ||
---|---|---|---|---|---|
Leu | Val | Ile | |||
1.28 | 0.65 | 0.54 | 0.0032 | 0.099 | 0.175c |
1.28 | 0.65 | 1.09 | 0.0035 | 0.110 | 0.230a,b,c |
1.28 | 1.2 | 0.54 | 0.0045 | 0.114 | 0.280a,b |
1.28 | 1.2 | 1.09 | 0.0029 | 0.095 | 0.187b,c |
1.83 | 0.65 | 0.54 | 0.0044 | 0.110 | 0.238a,b,c |
1.83 | 0.65 | 1.09 | 0.0044 | 0.130 | 0.285a,b |
1.83 | 1.2 | 0.54 | 0.0047 | 0.105 | 0.206b,c |
1.83 | 1.2 | 1.09 | 0.0050 | 0.172 | 0.322a |
SEM | 0.0007 | 0.016 | 0.032 | ||
SID Leu levels (%) | |||||
1.28 | 0.0035b | 0.105b | 0.218 | ||
1.83 | 0.0046a | 0.129a | 0.263 | ||
SEM | 0.0003 | 0.008 | 0.022 | ||
SID Val levels (%) | |||||
0.65 | 0.0039 | 0.113 | 0.232 | ||
1.2 | 0.0043 | 0.122 | 0.249 | ||
SEM | 0.0003 | 0.008 | 0.022 | ||
SID Ile levels (%) | |||||
0.54 | 0.0039 | 0.108 | 0.225 | ||
1.09 | 0.0043 | 0.127 | 0.256 | ||
SEM |
0.0003 |
0.008 |
0.022 |
||
Effects |
P-value |
||||
Leu | 0.01 | 0.03 | 0.10 | ||
Val | 0.37 | 0.42 | 0.46 | ||
Ile | 0.52 | 0.09 | 0.18 | ||
Leu x Val | 0.86 | 0.39 | 0.53 | ||
Leu x Ile | 0.38 | 0.04 | 0.03 | ||
Val x Ile | 0.39 | 0.70 | 0.38 | ||
Leu x Val x Ile | 0.21 | 0.10 | 0.02 |
a,b,cMeans in columns followed by different superscript letters are statistically different (P < 0.05).
Abbreviations: eEF2, eukaryotic translation elongation factor 2; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; mTOR, mechanistic target of rapamycin.
Data are means of 5 replicate cages per treatment (treatments = 8; n = 40). Samples were analyzed in duplicate.